Menu
Back to User profile » Dr Liang-Ping Xia
Papers published by Dr Liang-Ping Xia:
Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer
He WZ, Yang QX, Xie JY, Kong PF, Hu WM, Yang L, Yang YZ, Xie QK, Jiang C, Yin CX, Guo GF, Qiu HJ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:2499-2507
Published Date: 7 August 2018
An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients
He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:1597-1604
Published Date: 18 June 2018
Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2016, 9:877-883
Published Date: 23 February 2016
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L
OncoTargets and Therapy 2015, 8:3135-3142
Published Date: 27 October 2015
Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP
OncoTargets and Therapy 2015, 8:2407-2413
Published Date: 1 September 2015
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2014, 7:1415-1422
Published Date: 11 August 2014